EXEL vs UNH: fair value comparison
Exelixis, Inc. and UnitedHealth Group Incorporated · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, UNH currently sits closer to the top of our discount ranking. EXEL carries the stronger quality grade.
| EXEL | UNH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $56.89 | $379.09 |
| 12-month range | $38.06–$56.89 | $273.98–$415.36 |
| Sector rank | #53 of 113 Healthcare | #51 of 113 Healthcare |
| Quality grade | A | D |
| Leverage | Low | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Undervalued | Undervalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: EXEL fair value analysis · UNH fair value analysis